Highlights
- Market Cap
- $4.21B
- Enterprise Value
- $4.64B
- EPS (TTM)
- $0.28
- PE Ratio
- 91.08
- PEG Ratio
- 1.10
- Total Revenue (TTM)
- $2.72B
- Gross Profit (TTM)
- $1.49B
- EBITDA (TTM)
- $327.80M
- Year Range
- $14.22 - $30.42
- Target Price
- $24.71
- ROA (TTM)
- 0.83%
- ROE (TTM)
- 1.51%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Envista Holdings Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Envista Holdings Corporation (NVST) has returned 16.86% so far this year and 46.99% over the past 12 months.
Envista Holdings Corporation
- 1D
- 4.58%
- 1M
- -13.15%
- YTD
- 16.86%
- 6M
- 24.55%
- 1Y
- 46.99%
- 3Y*
- -14.70%
- 5Y*
- -9.08%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Sep 18, 2019, NVST's average daily return is +0.03%, while the average monthly return is +0.45%. At this rate, your investment would double in approximately 12.9 years.
Historically, 52% of months were positive and 48% were negative. The best month was Apr 2020 with a return of +30.3%, while the worst month was Mar 2020 at -41.1%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 6 months.
On a daily basis, NVST closed higher 49% of trading days. The best single day was Feb 6, 2026 with a return of +17.8%, while the worst single day was Mar 18, 2020 at -23.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 8.11% | 24.46% | -13.15% | 16.86% | |||||||||
| 2025 | 6.38% | -2.63% | -13.61% | -6.84% | 13.62% | 6.95% | -3.33% | 12.12% | -3.82% | -0.10% | 2.70% | 3.88% | 12.55% |
| 2024 | -2.33% | -12.13% | 3.54% | -7.95% | -1.63% | -14.10% | 2.65% | 6.97% | 8.21% | 6.12% | 6.29% | -13.46% | -19.83% |
| 2023 | 15.80% | -0.85% | 5.74% | -5.85% | -17.15% | 6.11% | 1.68% | -6.95% | -12.93% | -16.54% | -2.49% | 6.04% | -28.54% |
| 2022 | -4.04% | 11.01% | 1.48% | -18.66% | 8.63% | -10.46% | 5.47% | -8.76% | -11.54% | 0.61% | 3.36% | -1.32% | -25.28% |
| 2021 | 5.37% | 8.44% | 5.86% | 6.08% | 0.83% | -0.99% | -0.30% | -0.67% | -2.29% | -6.48% | -0.77% | 16.13% | 33.59% |
Benchmark Metrics
Envista Holdings Corporation has an annualized alpha of -8.18%, beta of 1.08, and R² of 0.30 versus S&P 500 Index. Calculated based on daily prices since September 19, 2019.
- This stock participated in 133.70% of S&P 500 Index downside but only 81.41% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.30 means the benchmark explains less than half of this stock's behavior — treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- -8.18%
- Beta
- 1.08
- R²
- 0.30
- Upside Capture
- 81.41%
- Downside Capture
- 133.70%
Return for Risk
Risk / Return Rank
NVST ranks 78 for risk / return — better than 78% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Envista Holdings Corporation (NVST) and compare them to a chosen benchmark (S&P 500 Index).
| NVST | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.11 | 0.90 | +0.21 |
Sortino ratioReturn per unit of downside risk | 1.92 | 1.39 | +0.53 |
Omega ratioGain probability vs. loss probability | 1.23 | 1.21 | +0.02 |
Calmar ratioReturn relative to maximum drawdown | 2.50 | 1.40 | +1.10 |
Martin ratioReturn relative to average drawdown | 7.08 | 6.61 | +0.47 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore NVST risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Envista Holdings Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Envista Holdings Corporation was 71.00%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current Envista Holdings Corporation drawdown is 50.16%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -71% | Mar 22, 2022 | 765 | Apr 8, 2025 | — | — | — |
| -64.13% | Jan 23, 2020 | 42 | Mar 23, 2020 | 197 | Dec 31, 2020 | 239 |
| -17.04% | May 10, 2021 | 120 | Oct 27, 2021 | 40 | Dec 23, 2021 | 160 |
| -11.54% | Feb 17, 2022 | 12 | Mar 7, 2022 | 9 | Mar 18, 2022 | 21 |
| -11.42% | Dec 28, 2021 | 22 | Jan 27, 2022 | 10 | Feb 10, 2022 | 32 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Envista Holdings Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Envista Holdings Corporation is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for NVST, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, NVST has a P/E ratio of 91.1. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for NVST compared to other companies in the Medical Instruments & Supplies industry. NVST currently has a PEG ratio of 1.1. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for NVST relative to other companies in the Medical Instruments & Supplies industry. Currently, NVST has a P/S ratio of 1.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for NVST in comparison with other companies in the Medical Instruments & Supplies industry. Currently, NVST has a P/B value of 1.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |